Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

COCHEnvoy Medical, Inc.

Nasdaq · CIK 0001840877
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
FY end1231
XBRL facts414

Identity from submissions API

NameEnvoy Medical, Inc.
CIK0001840877
TickersCOCH, COCHW
ExchangesNasdaq, Nasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
EIN861369123
LEI—
Fiscal year end1231
State of incorporation—
Phone651-361-8000
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Anzu Special Acquisition Corp I (2021-01-19T05:00:00.000Z → 2023-09-29T04:00:00.000Z)
Business address
4875 WHITE BEAR PARKWAY
WHITE BEAR LAKE
MN
55110
MN
Mailing address
4875 WHITE BEAR PARKWAY
WHITE BEAR LAKE
MN
55110
MN

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

330 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-05 10-Q QUARTERLY REPORT 0001213900-26-116117 001-40133 261524809 34 6854957 1 1
2026-11-05 8-K CURRENT REPORT 2.02,9.01 0001213900-26-116112 001-40133 261524740 34 367862 1 1
2026-10-27 8-K CURRENT REPORT 3.03,5.03,7.01,9.01 0001213900-26-112720 001-40133 261487518 34 297240 1 1
2026-10-16 8-K CURRENT REPORT 5.07,9.01 0001213900-26-110266 001-40133 261466447 34 247501 1 1
2026-10-07 8-K CURRENT REPORT 8.01,9.01 0001213900-26-107434 001-40133 261445595 34 238628 1 1
2026-09-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001094891-26-000284 005-93483 261377645 34 6901
2026-09-02 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-096772 001-40133 261355723 34 630810
2026-08-31 DEF 14A PROXY STATEMENT 0001213900-26-095756 001-40133 261346964 34 1905713
2026-08-27 8-K CURRENT REPORT 5.02,9.01 0001213900-26-094447 001-40133 261332006 34 365224 1 1
2026-08-26 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-26-000137 10758
2026-08-19 PRE 14A PROXY STATEMENT 0001213900-26-091704 001-40133 261295576 34 1906166
2026-08-10 8-K CURRENT REPORT 2.02,9.01 0001213900-26-087221 001-40133 261258261 34 363187 1 1
2026-08-10 10-Q QUARTERLY REPORT 0001213900-26-086974 001-40133 261256363 34 6036876 1 1
2026-06-30 8-K CURRENT REPORT 1.02,9.01 0001213900-26-073659 001-40133 261140405 34 261877 1 1
2026-06-25 8-K CURRENT REPORT 5.02,9.01 0001213900-26-072033 001-40133 261121826 34 297777 1 1
2026-06-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-26-000100 15915
2026-06-16 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002008 333-290927 261096484 33 1863
2026-06-12 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001213900-26-068309 333-290927 261087291 33 12727110 1 1
2026-06-12 S-8 REGISTRATION STATEMENT 0001213900-26-068305 333-296753 261087273 33 242457 1 1
2026-06-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-26-000095 12372
2026-05-22 8-K CURRENT REPORT 3.01 0001213900-26-060556 001-40133 261013677 34 245343 1 1
2026-05-18 8-K CURRENT REPORT 5.02,5.07,9.01 0001213900-26-058429 001-40133 26993140 34 283796 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062703 005-93483 26988979 34 11019
2026-05-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001171520-26-000099 005-93483 26980979 34 18774
2026-05-11 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-022322 005-93483 26964835 34 12203
2026-05-11 10-Q QUARTERLY REPORT 0001213900-26-054209 001-40133 26961006 34 5539258 1 1
2026-05-11 8-K CURRENT REPORT 2.02,9.01 0001213900-26-054185 001-40133 26960932 34 350614 1 1
2026-04-21 8-K CURRENT REPORT 5.02,9.01 0001213900-26-046197 001-40133 26879827 34 246630 1 1
2026-04-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-26-000077 5487
2026-04-17 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-26-000076 5088
2026-04-13 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-26-043011 001-40133 26858115 34 366296 1 1
2026-04-02 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-039313 001-40133 26833190 34 116244
2026-04-02 ARS ANNUAL REPORT 0001213900-26-039311 001-40133 26833180 34 1090480
2026-04-02 DEF 14A PROXY STATEMENT 0001213900-26-039310 001-40133 26833163 34 3954599 1 1
2026-03-31 8-K CURRENT REPORT 4.01,9.01 0001213900-26-037419 001-40133 26821630 34 263458 1 1
2026-03-27 8-K CURRENT REPORT 2.02,9.01 0001213900-26-035483 001-40133 26807111 34 357517 1 1
2026-03-23 PRE 14A REGISTRATION STATEMENT 0001213900-26-032947 001-40133 26782678 34 1125305 1 1
2026-03-23 10-K ANNUAL REPORT 0001213900-26-032683 001-40133 26780217 34 9946984 1 1
2026-02-27 8-K CURRENT REPORT 3.01,8.01,9.01 0001213900-26-021116 001-40133 26693092 34 260426 1 1
2026-02-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-26-000028 11981
2026-02-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-26-000027 12665
2026-02-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-26-000026 13838
2026-02-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-26-000025 11978
2026-02-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-26-000024 13473
2026-02-17 4 OWNERSHIP DOCUMENT 0001104659-26-016182 11783
2026-02-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-26-015955 005-93483 26637033 34 10559
2026-02-13 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-26-016584 001-40133 26634593 34 671433 1 1
2026-02-12 424B4 PROSPECTUS 0001213900-26-015232 333-293369 26623574 33 2774327
2026-02-12 424B4 PROSPECTUS 0001213900-26-015230 333-292260 26623572 33 2774327
2026-02-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000528 333-292260 26623092 33 1849
2026-02-11 8-K CURRENT REPORT 5.02,9.01 0001213900-26-014878 001-40133 26620601 34 248693 1 1
2026-02-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-006132 005-93483 26618708 34 11841
2026-02-11 S-1MEF REGISTRATION STATEMENT 0001213900-26-014612 333-293369 26618646 33 325924 1 1
2026-02-10 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-26-013894 333-292260 26613300 33 196926
2026-02-09 CORRESP filename1.htm 0001213900-26-013896 5342
2026-02-09 CORRESP filename1.htm 0001213900-26-013895 4550
2026-02-09 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-26-000015 5338
2026-02-09 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-26-000014 8733
2026-02-06 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-26-013098 333-292260 26605843 33 16084384 1 1
2025-12-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003951 333-290927 251615627 33 1850
2025-12-29 8-K CURRENT REPORT 1.01,9.01 0001213900-25-126032 001-40133 251609066 34 277815 1 1
2025-12-23 CORRESP filename1.htm 0001213900-25-125060 4697
2025-12-18 S-1 REGISTRATION STATEMENT 0001213900-25-123367 333-292260 251584052 33 15027257 1 1
2025-12-16 8-K CURRENT REPORT 7.01,9.01 0001213900-25-121987 001-40133 251573605 34 34742856 1 1
2025-12-10 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-25-000054 8889
2025-12-08 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-119019 005-93483 251554543 34 15171
2025-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-25-000052 6599
2025-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-25-000051 6608
2025-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-25-000050 7233
2025-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-25-000049 7152
2025-12-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0000914190-25-000048 7225
2025-12-03 8-K CURRENT REPORT 5.07,9.01 0001213900-25-117805 001-40133 251546389 34 253902 1 1
2025-12-01 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-25-116721 333-290927 251540060 33 15161806 1 1
2025-11-25 8-K FORM 8-K 3.01 0001213900-25-114725 001-40133 251520782 34 238121 1 1
2025-11-10 10-Q QUARTERLY REPORT 0001213900-25-107902 001-40133 251464554 34 6888007 1 1
2025-11-10 8-K CURRENT REPORT 2.02,9.01 0001213900-25-107898 001-40133 251464542 34 399911 1 1
2025-10-28 8-K CURRENT REPORT 3.01,8.01,9.01 0001213900-25-102828 001-40133 251421716 34 266589 1 1
2025-10-17 DEF 14A PROXY STATEMENT 0001213900-25-099960 001-40133 251400820 34 1759873
2025-10-17 S-1 REGISTRATION STATEMENT 0001213900-25-099775 333-290927 251399268 33 13629784 1 1
2025-10-09 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-25-097600 001-40133 251383718 34 860656 1 1
2025-10-09 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-097599 333-282474 251383712 33 411626
2025-10-07 PRE 14A PROXY STATEMENT 0001213900-25-097082 001-40133 251380448 34 1759649
2025-10-07 8-K CURRENT REPORT 8.01,9.01 0001213900-25-096845 001-40133 251378528 34 271381 1 1
2025-09-23 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-25-090373 001-40133 251332129 34 866586 1 1
2025-09-23 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-090369 333-282474 251332119 33 408762
2025-09-22 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-089737 333-282474 251328327 33 28682
2025-09-19 8-K CURRENT REPORT 8.01,9.01 0001213900-25-089225 001-40133 251324887 34 263904 1 1
2025-09-09 8-K CURRENT REPORT 1.01,9.01 0001213900-25-086268 001-40133 251304118 34 362673 1 1
2025-09-08 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-015411 40182
2025-09-02 UPLOAD filename1.pdf 0000000000-25-009438 377-08386 40609
2025-08-29 8-K CURRENT REPORT 3.01 0001213900-25-082608 001-40133 251281369 34 243738 1 1
2025-08-27 DRSLTR filename1.htm 0001213900-25-081198 5797
2025-08-27 DRS filename1.htm 0001213900-25-081194 377-08386 251266316 33 2448673
2025-08-26 8-K CURRENT REPORT 1.02,5.02,9.01 0001213900-25-080530 001-40133 251252699 34 296271 1 1
2025-08-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001094891-25-000020 005-93483 251240988 34 7180
2025-08-21 424B3 PROSPECTUS 0001213900-25-079248 333-276590 251239297 33 348644
2025-08-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002550 333-276590 251203852 33 1863
2025-08-08 POS AM POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 ON FORM S-3 0001213900-25-073704 333-276590 251198865 33 505902
2025-07-31 10-Q QUARTERLY REPORT 0001213900-25-069663 001-40133 251169582 34 6074955 1 1
2025-07-31 8-K CURRENT REPORT 2.02,9.01 0001213900-25-069658 001-40133 251169567 34 364608 1 1
2025-07-29 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 ON FORM S-3 0001213900-25-068821 333-276590 251163162 33 507931
2025-07-29 8-K CURRENT REPORT 1.01,9.01 0001213900-25-068760 001-40133 251162514 34 274418 1 1
2025-07-08 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-012617 17863
2025-07-03 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-012531 3071
2025-07-02 8-K CURRENT REPORT 1.01,2.03,3.02,9.01 0001213900-25-061057 001-40133 251101721 34 243431 1 1
2025-06-25 8-K CURRENT REPORT 5.02,9.01 0001213900-25-057481 001-40133 251071103 34 303946 1 1
2025-06-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-011661 6553
2025-06-10 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-011320 6554
2025-06-09 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-011296 10403
2025-06-03 8-K CURRENT REPORT 5.02,5.07,9.01 0001213900-25-050758 001-40133 251019207 34 475431 1 1
2025-05-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-010396 10387
2025-05-19 8-K CURRENT REPORT 5.02,9.01 0001213900-25-045109 001-40133 25961638 34 242841 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001315863-25-000389 005-93483 25949064 34 7151
2025-05-01 8-K CURRENT REPORT 2.02,9.01 0001213900-25-038498 001-40133 25903942 34 348717 1 1
2025-05-01 10-Q QUARTERLY REPORT 0001213900-25-038468 001-40133 25903519 34 6841559 1 1
2025-04-18 ARS FORM ARS 0001213900-25-033393 001-40133 25850612 34 1300419
2025-04-18 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-033390 001-40133 25850595 34 156011
2025-04-18 DEF 14A PROXY STATEMENT 0001213900-25-033385 001-40133 25850573 34 2479521
2025-04-11 8-K CURRENT REPORT 5.08 0001213900-25-030747 001-40133 25829463 34 253475 1 1
2025-03-31 8-K CURRENT REPORT 2.02,9.01 0001213900-25-025827 001-40133 25789226 34 370437 1 1
2025-03-31 10-K ANNUAL REPORT 0001013762-25-004299 001-40133 25788134 34 9977176 1 1
2025-03-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-005363 16478
2025-03-12 8-K CURRENT REPORT 1.01,2.03,3.02,9.01 0001213900-25-022913 001-40133 25729863 34 274298 1 1
2025-03-03 8-K CURRENT REPORT 3.01 0001213900-25-019425 001-40133 25698200 34 246944 1 1
2025-02-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-000542 005-93483 25596981 34 6980
2025-01-21 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-004715 333-282474 25540313 33 377510
2025-01-21 8-K CURRENT REPORT 1.01,9.01 0001213900-25-004714 001-40133 25539898 34 530079 1 1
2024-12-26 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001140361-24-050435 005-93483 241581971 34 47626
2024-12-26 4 FORM 4 0001140361-24-050422 4570
2024-12-26 4 FORM 4 0001140361-24-050420 12311
2024-12-23 424B3 PROSPECTUS SUPPLEMENT 0001213900-24-111936 333-276590 241574165 33 55864
2024-12-23 8-K CURRENT REPORT 1.01,9.01 0001213900-24-111932 001-40133 241574145 34 267242 1 1
2024-12-20 424B3 PROSPECTUS SUPPLEMENT 0001213900-24-111280 333-276590 241568975 33 82420
2024-12-20 8-K CURRENT REPORT 1.01,3.03,9.01 0001213900-24-111279 001-40133 241568960 34 307449 1 1
2024-12-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-020770 15070
2024-12-17 424B3 PROSPECTUS SUPPLEMENT 0001213900-24-109751 333-276590 241555562 33 53172
2024-12-17 8-K CURRENT REPORT 1.01,2.03,3.02,9.01 0001213900-24-109750 001-40133 241555557 34 257106 1 1
2024-12-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-020597 10281
2024-11-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019574 6015
2024-11-21 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019530 4738
2024-11-21 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019529 6730
2024-11-20 8-K CURRENT REPORT 5.07 0001213900-24-100544 001-40133 241480248 34 267715 1 1
2024-11-14 424B3 PROSPECTUS SUPPLEMENT 0001213900-24-097863 333-276590 241457505 33 1216224
2024-11-14 424B3 PROSPECTUS SUPPLEMENT 0001213900-24-097862 333-276590 241457492 33 245822
2024-11-14 10-Q QUARTERLY REPORT 0001213900-24-097861 001-40133 241457484 34 7075417 1 1
2024-11-14 8-K CURRENT REPORT 2.02,9.01 0001213900-24-097860 001-40133 241457481 34 470884 1 1
2024-11-14 SC 13G form_sc13g-envoy.htm 0001315863-24-000813 005-93483 241457472 34 53589
2024-11-13 SC 13G walleye-coch093024.htm 0001172661-24-004683 005-93483 241455086 34 54858
2024-10-21 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-10-21 16:00:00 9999999995-24-003224 333-282474 241384522 33 1857
2024-10-17 CORRESP filename1.htm 0001213900-24-088529 5678
2024-10-10 UPLOAD filename1.pdf 0000000000-24-011503 333-282474 40249
2024-10-04 ARS FORM ARS 0001213900-24-085582 001-40133 241355227 34 1339082
2024-10-04 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-24-085579 001-40133 241355218 34 1583121
2024-10-04 DEF 14A PROXY STATEMENT 0001213900-24-085572 001-40133 241355199 34 3405322
2024-10-03 S-3 REGISTRATION STATEMENT 0001213900-24-084734 333-282474 241349730 33 674637
2024-09-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-016486 7909
2024-09-06 8-K CURRENT REPORT 5.08 0001213900-24-076556 001-40133 241284947 34 264593 1 1
2024-08-29 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-015872 13676
2024-08-28 424B3 PROSPECTUS SUPPLEMENT 0001213900-24-073136 333-276590 241251291 33 58271
2024-08-28 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-24-073129 001-40133 241251177 34 278138 1 1
2024-08-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-014844 5387
2024-08-12 424B3 PROSPECTUS SUPPLEMENT 0001213900-24-067400 333-276590 241195074 33 569067
2024-08-12 424B3 PROSPECTUS SUPPLEMENT 0001213900-24-067391 333-276590 241195049 33 169115
2024-08-12 8-K CURRENT REPORT 2.02,9.01 0001213900-24-067387 001-40133 241195016 34 394207 1 1
2024-08-12 10-Q QUARTERLY REPORT 0001213900-24-067381 001-40133 241194972 34 5551415 1 1
2024-08-01 8-K CURRENT REPORT 8.01,9.01 0001013762-24-003342 001-40133 241163261 34 271134 1 1
2024-08-01 424B3 PROSPECTUS SUPPLEMENT 0001013762-24-003339 333-276590 241163253 33 57096
2024-08-01 8-K CURRENT REPORT 1.01,9.01 0001013762-24-003336 001-40133 241163239 34 268287 1 1
2024-07-25 424B3 PROSPECTUS SUPPLEMENT 0001013762-24-000822 333-276590 241139257 33 39344
2024-07-25 8-K CURRENT REPORT 1.01,2.03,3.02,9.01 0001013762-24-000821 001-40133 241139252 34 248656 1 1
2024-07-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-014054 12283
2024-07-17 424B3 PROSPECTUS SUPPLEMENT 0001213900-24-061923 333-276590 241120962 33 45603
2024-07-17 424B3 PROSPECTUS SUPPLEMENT 0001213900-24-061922 333-276590 241120958 33 10399994
2024-07-15 8-K CURRENT REPORT 7.01,9.01 0001213900-24-061178 001-40133 241115925 34 10642621 1 1
2024-06-26 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-013065 9288
2024-06-25 424B3 PROSPECTUS SUPPLEMENT 0001213900-24-055743 333-276590 241069193 33 52421
2024-06-25 8-K CURRENT REPORT 1.01,9.01 0001213900-24-055739 001-40133 241069144 34 262756 1 1
2024-06-17 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-012700 4977
2024-06-11 8-K CURRENT REPORT 5.02,7.01,9.01 0001213900-24-051511 001-40133 241034630 34 277575 1 1
2024-05-29 424B3 PROSPECTUS SUPPLEMENT 0001213900-24-047523 333-276590 24999406 33 618075
2024-05-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-011337 10889
2024-05-24 8-K CURRENT REPORT 1.01,2.03,3.02,9.01 0001213900-24-046417 001-40133 24980856 34 249643 1 1
2024-05-15 8-K CURRENT REPORT 2.02,9.01 0001213900-24-043601 001-40133 24950580 34 425123 1 1
2024-05-15 10-Q QUARTERLY REPORT 0001213900-24-043566 001-40133 24950159 34 5471165 1 1
2024-05-02 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-05-02 16:05:00 9999999995-24-001348 333-276590 24910654 33 1856
2024-05-02 424B3 PROSPECTUS 0001213900-24-039132 333-276590 24908613 33 6695854
2024-04-30 CORRESP filename1.htm 0001213900-24-037897 7117
2024-04-25 S-1/A REGISTRATION STATEMENT 0001213900-24-036229 333-276590 24876792 33 17022564 1 1
2024-04-12 S-8 REGISTRATION STATEMENT 0001213900-24-032602 333-278662 24842153 33 109777
2024-04-05 S-1/A REGISTRATION STATEMENT 0001213900-24-030821 333-276590 24826523 33 17114060 1 1
2024-04-01 10-K ANNUAL REPORT 0001213900-24-028894 001-40133 24810903 34 8073016 1 1
2024-03-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-005235 9164
2024-03-04 8-K CURRENT REPORT 1.01,2.03,3.02,9.01 0001213900-24-019277 001-40133 24713045 34 279985 1 1
2024-02-15 S-1/A REGISTRATION STATEMENT 0001213900-24-014271 333-276590 24641780 33 25659973 1 1
2024-02-14 CORRESP filename1.htm 0001213900-24-014273 25874
2024-02-12 SC 13G/A form_envoymedical_sc13ga.htm 0001315863-24-000216 005-93483 24620452 34 49096
2024-01-29 UPLOAD filename1.pdf 0000000000-24-001118 333-276590 50247
2024-01-18 S-1 REGISTRATION STATEMENT 0001213900-24-004577 333-276590 24542636 33 25115394 1 1
2024-01-17 10-Q/A AMENDMENT NO. 1 TO FORM 10-Q 0001213900-24-004149 001-40133 24538599 34 6426161 1 1
2023-12-19 8-K CURRENT REPORT 4.02 0001213900-23-096921 001-40133 231497285 34 253704 1 1
2023-12-04 4/A AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021838 8370
2023-11-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021438 9440
2023-11-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-021360 7919
2023-11-17 10-Q QUARTERLY REPORT 0001213900-23-088310 001-40133 231418492 34 5992610 1 1
2023-11-14 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-23-086949 001-40133 231406342 34 22048
2023-10-24 8-K CURRENT REPORT 4.01,9.01 0001013762-23-006340 001-40133 231343373 34 263464 1 1
2023-10-20 8-K CURRENT REPORT 5.02,9.01 0001013762-23-005437 001-40133 231337149 34 357012 1 1
2023-10-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-019481 5910
2023-10-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-019479 8067
2023-10-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-019448 5262
2023-10-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-019443 5279
2023-10-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-019440 5347
2023-10-17 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-019436 5273
2023-10-10 8-K CURRENT REPORT 8.01,9.01 0001013762-23-002893 001-40133 231318733 34 281699 1 1
2023-10-10 8-K/A AMENDMENT NO. 1 TO FORM 8-K 9.01 0001013762-23-002589 001-40133 231315037 34 604596 1 1
2023-10-05 8-K CURRENT REPORT 1.01,2.01,3.01,3.02,3.03,5.01,5.02,5.03,5.06,9.01 0001013762-23-002246 001-40133 231312264 34 1808478 1 1
2023-10-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-018937 23247
2023-10-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-018936 7260
2023-10-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-018935 7056
2023-10-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-018934 7359
2023-10-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-018933 7271
2023-10-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-018900 9740
2023-10-02 8-K FORM 8-K 7.01,8.01,9.01 0001104659-23-105488 001-40133 231297254 34 300146 1 1
2023-09-29 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-018648 5056
2023-09-29 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-018646 5085
2023-09-29 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-018644 5049
2023-09-29 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-018642 5042
2023-09-29 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-018641 7860
2023-09-29 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-018638 8575
2023-09-29 25-NSE xslF25X02/primary_doc.xml 0001354457-23-000714 333-252861 231295454 34 2932
2023-09-27 8-K FORM 8-K 5.07,7.01,9.01 0001104659-23-104294 001-40133 231285029 34 348299 1 1
2023-09-15 DEFA14A DEFA14A 0001104659-23-101011 001-40133 231256812 34 7892049
2023-09-15 425 425 0001104659-23-101009 001-40133 231256806 34 7892751
2023-09-15 8-K FORM 8-K 8.01,9.01 0001104659-23-101007 001-40133 231256799 34 8157290 1 1
2023-09-15 DEF 14A DEF 14A 0001104659-23-100932 001-40133 231256619 34 2639787
2023-09-14 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2023-09-14 16:05:00 9999999995-23-002658 333-271920 231256565 33 1725
2023-09-14 424B3 424B3 0001104659-23-100792 333-271920 231255281 33 9066367
2023-09-14 CORRESP filename1.htm 0001104659-23-100668 178747
2023-09-13 CORRESP filename1.htm 0001104659-23-100384 5730
2023-09-13 S-4/A S-4/A 0001104659-23-100182 333-271920 231251527 33 9181259
2023-09-12 CORRESP filename1.htm 0001104659-23-100183 17285
2023-09-12 UPLOAD filename1.pdf 0000000000-23-010058 44215
2023-09-05 PRE 14A PRE 14A 0001104659-23-098300 001-40133 231236520 34 485083
2023-09-05 S-4/A S-4/A 0001104659-23-097879 333-271920 231233886 33 9976655
2023-09-01 CORRESP filename1.htm 0001104659-23-097887 37399
2023-09-01 UPLOAD filename1.pdf 0000000000-23-009737 45457
2023-08-24 425 425 0001104659-23-094925 001-40133 231202826 34 28989
2023-08-24 S-4/A FORM S-4/A 0001104659-23-094601 333-271920 231198614 33 22821880 1 1
2023-08-23 CORRESP filename1.htm 0001104659-23-094602 40103
2023-08-18 UPLOAD filename1.pdf 0000000000-23-009071 57938
2023-08-14 10-Q 10-Q 0001410578-23-001937 001-40133 231172196 34 5764708 1 1
2023-08-04 CORRESP filename1.htm 0001104659-23-087917 80677
2023-08-04 S-4/A S-4/A 0001104659-23-087916 333-271920 231144839 33 10033838
2023-07-28 UPLOAD filename1.pdf 0000000000-23-008113 76334
2023-06-30 CORRESP filename1.htm 0001104659-23-077230 130656
2023-06-30 S-4/A FORM S/4 0001104659-23-077199 333-271920 231062540 33 22400903 1 1
2023-06-13 UPLOAD filename1.pdf 0000000000-23-006362 101535
2023-05-15 10-Q FORM 10-Q 0001104659-23-060855 001-40133 23923361 34 5293551 1 1
2023-05-15 S-4 FORM S-4 0001104659-23-060442 333-271920 23919601 33 14879702 1 1
2023-04-18 425 425 0001104659-23-046446 001-40133 23825574 34 1516010
2023-04-18 8-K FORM 8-K 1.01,1.02,3.02,9.01 0001104659-23-046443 001-40133 23825566 34 2099427 1 1
2023-04-03 10-K FORM 10-K 0001104659-23-040842 001-40133 23792751 34 7457027 1 1
2023-04-03 NT 10-K NT 10-K 0001104659-23-040834 001-40133 23792684 34 23786
2023-04-03 8-K FORM 8-K 4.02 0001104659-23-040830 001-40133 23792627 34 266130 1 1
2023-03-31 4 PRIMARY DOCUMENT 0000312069-23-000067 4121
2023-03-31 3 PRIMARY DOCUMENT 0000312069-23-000061 7120
2023-03-13 3 OWNERSHIP DOCUMENT 0000950142-23-000682 5233
2023-03-02 8-K FORM 8-K 5.03,5.07,8.01,9.01 0001104659-23-027594 001-40133 23696311 34 293802 1 1
2023-02-24 DEFA14A DEFA14A 0001104659-23-024999 001-40133 23662347 34 126060
2023-02-24 8-K FORM 8-K 1.01,9.01 0001104659-23-024997 001-40133 23662345 34 379895 1 1
2023-02-22 DEFA14A DEFA14A 0001104659-23-024117 001-40133 23650703 34 20582265
2023-02-22 425 425 0001104659-23-024115 001-40133 23650691 34 8394505
2023-02-22 8-K FORM 8-K 8.01,9.01 0001104659-23-024112 001-40133 23650684 34 8665342 1 1
2023-02-21 DEFA14A DEFA14A 0001104659-23-023821 001-40133 23648922 34 20313
2023-02-21 8-K FORM 8-K 7.01,9.01 0001104659-23-023809 001-40133 23648804 34 280136 1 1
2023-02-21 DEFA14A DEFA14A 0001104659-23-023528 001-40133 23645264 34 29226
2023-02-15 UPLOAD filename1.pdf 0000000000-23-001547 248937
2023-02-14 SC 13G/A anzu20221231.htm 0001076809-23-000039 005-93483 23620485 34 66409
2023-02-13 SC 13G/A sc_13ga_anzu.htm 0001315863-23-000244 005-93483 23616166 34 95363
2023-02-09 DEFA14A DEFA14A 0001104659-23-017663 001-40133 23607259 34 21270
2023-02-09 8-K FORM 8-K 7.01,9.01 0001104659-23-017660 001-40133 23607225 34 276293 1 1
2023-02-06 DEFA14A DEFA14A 0001104659-23-010918 001-40133 23588542 34 9217154
2023-02-06 425 425 0001104659-23-010915 001-40133 23588534 34 9204230
2023-02-06 8-K FORM 8-K 8.01,9.01 0001104659-23-010912 001-40133 23588527 34 9504585 1 1
2023-02-03 DEFA14A DEFA14A 0001104659-23-010069 001-40133 23583436 34 33333
2023-01-20 DEF 14A DEF 14A 0001104659-23-005468 001-40133 23541953 34 2397851
2023-01-19 UPLOAD filename1.pdf 0000000000-23-000569 39768
2023-01-18 CORRESP filename1.htm 0001104659-23-004641 67772
2023-01-11 UPLOAD filename1.pdf 0000000000-23-000268 45010
2022-12-29 PRE 14A PRE 14A 0001104659-22-130616 001-40133 221496052 34 2796574
2022-11-14 10-Q FORM 10-Q 0001104659-22-118526 001-40133 221385169 34 5908034 1 1
2022-10-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-020353 6046
2022-10-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-020354 8143
2022-10-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-020352 6005
2022-10-04 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-020351 6247
2022-10-04 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-020350 6206
2022-10-04 8-K FORM 8-K 5.02 0001104659-22-105831 001-40133 221291561 34 266574 1 1
2022-08-15 10-Q FORM 10-Q 0001104659-22-091412 001-40133 221167471 34 5713022 1 1
2022-08-04 8-K FORM 8-K 3.01,5.02,9.01 0001104659-22-086142 001-40133 221136805 34 292807 1 1
2022-05-16 10-Q FORM 10Q 0001104659-22-061413 001-40133 22930204 34 4851813 1 1
2022-03-31 10-K FORM 10-K 0001104659-22-041094 001-40133 22793411 34 5861938 1 1
2022-02-14 SC 13G anzu20211231.htm 0001076809-22-000009 005-93483 22629557 34 65164
2022-02-14 SC 13G SC 13G 0001193125-22-039897 005-93483 22626003 34 41300
2022-01-26 8-K/A FORM 8-K/A 9.01 0001104659-22-007887 001-40133 22558900 34 449797 1 1
2022-01-03 10-Q/A FORM 10-Q/A 0001104659-21-154834 001-40133 211534200 34 5121005 1 1
2021-12-07 8-K FORM 8-K 1.01,3.02,7.01,9.01 0001104659-21-147265 001-40133 211476766 34 739281 1 1
2021-12-03 8-K FORM 8-K 4.02 0001104659-21-146397 001-40133 211470871 34 262393 1 1
2021-11-12 10-Q 10-Q 0001104659-21-138123 001-40133 211404101 34 4650466 1 1
2021-08-18 10-Q anzuu-20210630x10q.htm 0001104659-21-107102 001-40133 211184568 34 4427671 1 1
2021-08-17 NT 10-Q NT 10-Q 0001104659-21-107048 001-40133 211183544 34 18304
2021-05-17 10-Q FORM 10-Q 0001104659-21-068312 001-40133 21932502 34 4183368 1 1
2021-04-22 8-K FORM 8-K 8.01,9.01 0001104659-21-053305 001-40133 21842908 34 34228
2021-04-20 8-K FORM 8-K 8.01,9.01 0001104659-21-052594 001-40133 21838522 34 87081
2021-03-10 8-K FORM 8-K 8.01,9.01 0001104659-21-034575 001-40133 21730979 34 121747
2021-03-04 8-K FORM 8-K 8.01,9.01 0001104659-21-032172 001-40133 21715020 34 990419
2021-03-03 424B4 424B4 0001104659-21-031572 333-252861 21710364 33 1890672
2021-03-01 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-03-01 16:00:00 9999999995-21-000779 333-252861 21701154 33 1655
2021-03-01 3 PRIMARY DOCUMENT 0000925421-21-000101 13211
2021-03-01 3 PRIMARY DOCUMENT 0000925421-21-000099 7877
2021-03-01 3 PRIMARY DOCUMENT 0000925421-21-000097 7832
2021-03-01 3 PRIMARY DOCUMENT 0000925421-21-000095 7869
2021-03-01 3 PRIMARY DOCUMENT 0000925421-21-000093 6091
2021-03-01 3 PRIMARY DOCUMENT 0000925421-21-000091 5956
2021-03-01 3 PRIMARY DOCUMENT 0000925421-21-000089 5995
2021-03-01 S-1MEF S-1MEF 0001104659-21-030238 333-253755 21700518 33 68471
2021-03-01 CERT 8A_Cert_ANZU.pdf 0001354457-21-000279 001-40133 21695731 34 292294
2021-03-01 8-A12B FORM 8-A12B 0001104659-21-029657 001-40133 21693857 34 19621
2021-02-19 S-1/A AMENDMENT TO SCHEDULE S-1 0001104659-21-025855 333-252861 21657294 33 2741656
2021-02-08 S-1 S-1 0001104659-21-014526 333-252861 21602688 33 3399737
2021-01-19 DRS filename1.htm 0001104659-21-005291 377-04055 21535415 33 1977920

Latest XBRL company facts

One latest value per concept from companyfacts (414 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 7.74M 2026-11-05 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
dei EntityPublicFloat Entity Public Float USD 12.70M 2025-12-31 2025 FY 10-K/A 2026-04-13 0001213900-26-043011
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 82,625 2021-03-31 2021 Q1 10-Q 2021-05-17 0001104659-21-068312
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.58M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 51,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap AccruedInsuranceCurrent Accrued Insurance, Current USD 1.51M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 11.60M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 385,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 5.33M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -123,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 330.19M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 179,380 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043566
us-gaap AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD 4.50M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 1.68M 2024-01-01 2024-03-31 2025 Q2 10-Q 2025-07-31 0001213900-25-069663
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 214,000 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-10 0001213900-26-086974
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 280,500 2021-04-01 2021-06-30 2021 Q2 10-Q 2021-08-18 0001104659-21-107102
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 882,000 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 44,000 2026-01-01 2026-03-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 282,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 1.59M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 5.87M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107902
us-gaap AreaOfLand Area of Land sqm 13,447 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2024-01-01 2024-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap Assets Assets USD 19.16M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap AssetsCurrent Assets, Current USD 17.26M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap AssetsFairValueAdjustment Assets, Fair Value Adjustment USD 1.20M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 44.65M 2023-06-30 2023 Q2 10-Q 2023-08-14 0001410578-23-001937
us-gaap AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare Auction Market Preferred Securities, Stock Series, Par Value Per Share USD/shares 15 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-097861
us-gaap BenefitsLossesAndExpenses Benefits, Losses and Expenses USD 100,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap BusinessAcquisitionSharePrice Business Acquisition, Share Price USD/shares 9.2 2021-03-31 2021 Q1 10-Q 2021-05-17 0001104659-21-068312
us-gaap BusinessCombinationConsiderationTransferredOther1 Business Combination, Consideration Transferred, Other USD 100,000 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 117,000 2024-01-01 2024-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap Cash Cash USD 14.57M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 4.22M 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 14.57M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 10.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2023-06-30 2023 Q2 10-Q 2023-08-14 0001410578-23-001937
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 5.40M 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-097861
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 4 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067381
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 3.87M 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067381
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.00M 2024-07-29 2025 Q2 10-Q 2025-07-31 0001213900-25-069663
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 105,000 2025-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107902
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 4.00M 2023-04-17 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap CommonStockConvertibleConversionPriceIncrease Common Stock, Convertible, Conversion Price, Increase USD/shares 1 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2025-06-30 2025 Q2 10-Q 2025-07-31 0001213900-25-069663
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 400.00M 2025-06-30 2025 Q2 10-Q 2025-07-31 0001213900-25-069663
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 21.52M 2025-06-30 2025 Q2 10-Q 2025-07-31 0001213900-25-069663
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 18.73M 2024-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107902
us-gaap CommonStockValue Common Stock, Value, Issued USD 8,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap CommonStockValueOutstanding Common Stock, Value, Outstanding USD 750,000 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -14.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 1.16M 2024-01-01 2024-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 2.62M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 2.50M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap ConvertibleDebt Convertible Debt USD 59.00M 2022-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 33.40M 2022-12-31 2023 Q3 10-Q 2023-11-17 0001213900-23-088310
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 2.50M 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 448,000 2022-12-31 2023 Q3 10-Q 2023-11-17 0001213900-23-088310
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 835,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap CostOfRevenue Cost of Revenue USD 835,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap CostsAndExpenses Costs and Expenses USD 17.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 100,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107902
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 1.18M 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-03 0001104659-23-040842
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 325,880 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-03 0001104659-23-040842
us-gaap DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 Debt Conversion, Converted Instrument, Warrants or Options Issued shares 70,000 2023-04-01 2023-04-17 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 2.23M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001104659-23-060855
us-gaap DebtInstrumentIssuedPrincipal DebtInstrumentIssuedPrincipal USD 4.00M 2023-04-17 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 1.28M 2024-12-31 2025 Q3 10-Q 2025-11-10 0001213900-25-107902
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 197,000 2024-05-23 2024 Q2 10-Q 2024-08-12 0001213900-24-067381
us-gaap DebtInstrumentUnusedBorrowingCapacityAmount Debt Instrument, Unused Borrowing Capacity, Amount USD 4.00M 2023-04-17 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 94,992 2020-12-31 2021 FY 10-K 2022-03-31 0001104659-22-041094
us-gaap DeferredCostsAndOtherAssets Deferred Costs and Other Assets USD 3.13M 2024-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 94,992 2020-12-31 2021 Q1 10-Q 2021-05-17 0001104659-21-068312
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -1.89M 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 67,000 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 2.58M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 808,000 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 94,992 2022-12-31 2022 FY 10-K 2023-04-03 0001104659-23-040842
us-gaap DeferredRevenueRefundPayments1 Deferred Revenue, Refund Payments USD 2.50M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -794,000 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD 418,000 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 50.97M 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 2.06M 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 808,000 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 42.30M 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 180.00M 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 49.00M 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.69M 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 1.70M 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsOther Deferred Tax Assets, Tax Credit Carryforwards, Other USD 3.69M 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 31,000 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 50.16M 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 433,000 2024-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap DeferredTaxLiabilitiesDerivatives Deferred Tax Liabilities, Derivatives USD 532,000 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD -276,000 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.15 2023-09-30 POS AM 2026-06-12 0001213900-26-068309
us-gaap DepositLiabilityCurrent Deposit Liability, Current USD 300,000 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap Depreciation Depreciation USD 222,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap DerivativeAssetsLiabilitiesAtFairValueNet Derivative Assets (Liabilities), at Fair Value, Net USD 2.39M 2023-09-30 2023 Q3 10-Q 2023-11-17 0001213900-23-088310
us-gaap DerivativeAssetsNoncurrent Derivative Asset, Noncurrent USD 353,731 2022-12-31 2023 Q2 10-Q 2023-08-14 0001410578-23-001937
us-gaap DerivativeFairValueOfDerivativeNet Derivative, Fair Value, Net USD 14.60M 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 411,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap DerivativeGainOnDerivative Derivative, Gain on Derivative USD 200,000 2023-04-01 2023-04-17 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 311,000 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 332,000 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap Dividends Dividends USD 3.73M 2026-01-01 2026-03-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 7.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 3.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap DividendsPreferredStockCash Dividends, Preferred Stock, Cash USD 1.31M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 185,580 2021-06-30 2021 Q2 10-Q 2021-08-18 0001104659-21-107102
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.97 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.97 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.034 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent pure 0.002 2024-01-01 2024-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.003 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD -164,000 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure 0.007 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.002 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.007 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlements Effective Income Tax Rate Reconciliation, Tax Settlement, Percent pure 0.5 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsOther Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Percent pure -0.006 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -1,000 2023-01-01 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 37,000 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 2.43M 2026-06-30 2026 Q2 10-Q 2026-08-10 0001213900-26-086974
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 2.39M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap EmployeeStockOwnershipPlanESOPCompensationExpense Employee Stock Ownership Plan (ESOP), Compensation Expense USD 1.60M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap ExcessStockSharesIssued Excess Stock, Shares Issued shares 1.15M 2022-07-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 32.01M 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -24,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap FairValueHedgeAssetsAtFairValue Fair Value Hedge Assets USD 36.80M 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 8.00M 2021-01-01 2021-09-30 2021 Q3 10-Q/A 2022-01-03 0001104659-21-154834
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 19.20M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001104659-22-118526
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 269,667 2021-04-12 2022 Q1 10-Q 2022-05-16 0001104659-22-061413
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 1.87M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001104659-22-118526
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues USD 103,000 2021-04-01 2021-06-30 2022 Q3 10-Q 2022-11-14 0001104659-22-118526
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) USD -4.05M 2021-07-01 2021-09-30 2022 Q3 10-Q 2022-11-14 0001104659-22-118526
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 51.40M 2023-01-01 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD 103,000 2024-01-01 2024-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 600,000 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 1.79M 2023-09-30 2023 Q3 10-Q 2023-11-17 0001213900-23-088310
us-gaap FinancingReceivableExcludingAccruedInterestNonaccrualPercentPastDue FinancingReceivableExcludingAccruedInterestNonaccrualPercentPastDue pure 0.8 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 10.00M 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 231,000 2023-01-01 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 27.88M 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 6.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -23.53M 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -23.76M 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -222,000 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1.69M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001410578-23-001937
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 962,768 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001410578-23-001937
us-gaap IncomeTaxReceivable Income Taxes Receivable USD 800,000 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -800,000 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -4.99M 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 72,000 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 3,000 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 155,000 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD -757,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -1.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -13,069 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-17 0001104659-21-068312
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 17,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 13,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap IncreaseDecreaseInAccruedTaxesPayable Increase (Decrease) in Accrued Taxes Payable USD 1.18M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001410578-23-001937
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD -6,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043566
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD -144,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 4.00M 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-097861
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD 13,803 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-17 0001104659-21-068312
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -26,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -205,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -868,000 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 149,090 2021-01-01 2021-06-30 2022 Q2 10-Q 2022-08-15 0001104659-22-091412
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 105,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 661,433 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001410578-23-001937
us-gaap InterestExpenseDebt Interest Expense, Debt USD 1.59M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap InterestExpenseLongTermDebt Interest Expense, Long-term Debt USD 100,000 2025-08-25 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 1.59M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap InterestExpenseOther Interest Expense, Other USD 1.59M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 19,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap InterestPayableCurrent Interest Payable, Current USD 703,000 2024-12-31 2025 Q2 10-Q 2025-07-31 0001213900-25-069663
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 150,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 157,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap InventoryLIFOReservePeriodCharge Inventory, LIFO Reserve, Period Charge USD 10,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap InventoryNet Inventory, Net USD 1.51M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 1.27M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 82,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap InventoryWriteDown Inventory Write-down USD 262,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067381
us-gaap InvestmentCompanyIssuanceOfSharesPerShare InvestmentCompanyIssuanceOfSharesPerShare USD/shares 10 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 3.90M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001410578-23-001937
us-gaap InvestmentInterestRate Investment Interest Rate pure 0.08 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 140,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap LandSubjectToGroundLeases Land Subject to Ground Leases sqm 1,664 2024-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap LeaseCost Lease, Cost USD 206,000 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap LeaseDepositLiability Lease Deposit Liability USD 777,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1.15M 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 151,000 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 255,000 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 186,000 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 229,000 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 222,000 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 254,000 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 185,000 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 227,000 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap Liabilities Liabilities USD 20.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 19.16M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap LiabilitiesCurrent Liabilities, Current USD 14.27M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment USD -262,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043566
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 3.07M 2023-09-30 2023 Q3 10-Q 2023-11-17 0001213900-23-088310
us-gaap LineOfCreditFacilityAnnualPrincipalPayment Line of Credit Facility, Annual Principal Payment USD 5.00M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap LineOfCreditFacilityIncreaseAccruedInterest Line of Credit Facility, Increase, Accrued Interest USD 29.44M 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap LineOfCreditFacilityInterestRateDuringPeriod Line of Credit Facility, Interest Rate During Period pure 0.045 2023-04-17 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 4.00M 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 5.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap LoansPayable Loans Payable USD 9.33M 2024-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap LongTermDebtAverageAmountOutstanding LongTermDebtAverageAmountOutstanding USD 4.30M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 9.40M 2023-11-14 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 27.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -33,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -16.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -14.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap NetIncomeLossAllocatedToGeneralPartners Net Income (Loss) Allocated to General Partners USD -25.03M 2023-01-01 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -18.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -18.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1 Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued shares 8,512 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043566
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 443,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap NotesPayable Notes Payable USD 4.00M 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap NotesPayableFairValueDisclosure Notes Payable, Fair Value Disclosure USD 1.50M 2022-06-30 2022 Q2 10-Q 2022-08-15 0001104659-22-091412
us-gaap NotesPayableRelatedPartiesCurrentAndNoncurrent Notes Payable, Related Parties USD 185,580 2021-06-30 2021 Q2 10-Q 2021-08-18 0001104659-21-107102
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 2.59M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001410578-23-001937
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -17.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap OperatingLeaseCost Operating Lease, Cost USD 206,000 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap OperatingLeaseLeaseIncomeLeasePayments Operating Lease, Lease Income, Lease Payments USD 239,000 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 919,000 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap OperatingLeasePayments Operating Lease, Payments USD 50 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.099 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 304,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap OtherAdditionalCapital Other Additional Capital USD 10.00M 2025-12-31 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -1,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043566
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD -1,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043566
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax USD 6,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap OtherExpenses Other Expenses USD 697,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap OtherGeneralExpense Other General Expense USD 300,000 2023-01-01 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap OtherIntangibleAssetsNet Other Intangible Assets, Net USD 7.50M 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap OtherLiabilities Other Liabilities USD 6,000 2025-06-30 2025 Q2 10-Q 2025-07-31 0001213900-25-069663
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 650,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 27,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap OtherLongTermDebtCurrent Other Long-term Debt, Current USD 2.50M 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067381
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 303,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 17,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 156,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap OtherRestrictedAssets Other Restricted Assets USD 4.00M 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap OtherRestrictedAssetsNoncurrent Other Restricted Assets, Noncurrent USD 5.40M 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap OtherSellingAndMarketingExpense Other Selling and Marketing Expense USD 63,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap PaymentsForOtherDeposits Payments for Other Deposits USD 542,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067381
us-gaap PaymentsForProceedsFromPreviousAcquisition Payments for (Proceeds from) Previous Acquisition USD 10.00M 2023-04-17 2024 Q1 10-Q 2024-05-15 0001213900-24-043566
us-gaap PaymentsForPurchaseOfOtherAssets1 Payments for Purchase of Other Assets USD 10.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap PaymentsOfDividends Payments of Dividends USD 1.82M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 572,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 62,000 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap PaymentsToAcquireOtherProductiveAssets Payments to Acquire Other Productive Assets USD 542,000 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-07-31 0001213900-25-069663
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 109,000 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 33,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap PercentageOfWeightedAverageCostInventory Percentage of Weighted Average Cost Inventory pure 0.037 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-097861
us-gaap PreferredStockConvertibleConversionPrice PreferredStockConvertibleConversionPrice USD/shares 115 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 2.73M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067381
us-gaap PreferredStockDividendsPerShareCashPaid Preferred Stock, Dividends, Per Share, Cash Paid USD/shares 10 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2025-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107902
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 100.00M 2025-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107902
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 4.13M 2025-06-30 2025 Q2 10-Q 2025-07-31 0001213900-25-069663
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 4.13M 2025-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107902
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 260,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap PrepaidExpenseAndOtherAssetsNoncurrent Prepaid Expense and Other Assets, Noncurrent USD 390,000 2025-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107902
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 264,924 2023-06-30 2023 Q2 10-Q 2023-08-14 0001410578-23-001937
us-gaap PrepaymentFeesOnAdvancesNet Prepayment Fees on Advances, Net USD 4.45M 2026-01-01 2026-03-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap ProceedsFromCollectionOfLongtermLoansToRelatedParties Proceeds from Collection of Long-term Loans to Related Parties USD 30.00M 2026-01-01 2026-03-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 1.00M 2023-01-01 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 10.00M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 414,000 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 414,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 30.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 1.00M 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-097861
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 63,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 2.50M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 1.68M 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-07-31 0001213900-25-069663
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 91,000 2023-01-01 2023-06-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 1.68M 2024-01-01 2024-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap ProceedsFromPreviousAcquisition Proceeds from Previous Acquisition USD 100,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 10.00M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap ProceedsFromSaleOfOtherReceivables Proceeds from Sale of Other Receivables USD 1.70M 2024-02-29 2024 Q3 10-Q 2024-11-14 0001213900-24-097861
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 104,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 3.11M 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap ProductLiabilityContingencyAccrualDiscountRate Product Liability Contingency, Accrual, Discount Rate pure 0.058 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap ProductWarrantyAccrual Standard and Extended Product Warranty Accrual USD 1.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap ProductWarrantyAccrualClassifiedCurrent Product Warranty Accrual, Current USD 252,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap ProductWarrantyAccrualNoncurrent Product Warranty Accrual, Noncurrent USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -420,544 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001410578-23-001937
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 6.18M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 854,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap RelatedPartiesAmountInCostOfSales Related Parties Amount in Cost of Sales USD 500,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology Related Party Tax Expense Effect of Change in Allocation Methodology USD 95,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107902
us-gaap RepaymentsOfOtherDebt Repayments of Other Debt USD 100,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 9.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 5.40M 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -331.61M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap RetainedEarningsAppropriated Retained Earnings, Appropriated USD 264.90M 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043566
us-gaap Revenues Revenues USD 156,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 121,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 1.68M 2024-02-29 POS AM 2026-06-12 0001213900-26-068309
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 8,512 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 4 2024-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap SalesAndExciseTaxPayableCurrent Sales and Excise Tax Payable, Current USD 1.68M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap SalesAndExciseTaxPayableCurrentAndNoncurrent Sales and Excise Tax Payable USD 2.20M 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap SecuritiesPurchasedUnderAgreementsToResell Securities Purchased under Agreements to Resell USD 11.70M 2023-09-30 2024 Q1 10-Q 2024-05-15 0001213900-24-043566
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD -2.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 502,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 7.28M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap SeparateAccountLiabilityWithdrawal SeparateAccountLiabilityWithdrawal USD 2.00M 2023-09-01 2023-09-30 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 760,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 720.50M 2023-10-15 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2023-01-01 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.76 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.044 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 5.87M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107902
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 5.87M 2025-09-30 2025 Q3 10-Q 2025-11-10 0001213900-25-107902
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 100,000 2023-01-01 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 841.07M 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-097861
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 962,082 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-097861
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 2.4 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-097861
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 35,865 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-097861
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 302,115 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 146.63M 2023-12-11 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 348,280 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.78 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 994,907 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 8,865 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 1.83 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 1.75 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 4.96M 2024-12-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.26M 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease) shares 3.91M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 2.18 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 1.45M 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 2.38 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 1.45M 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 74,356 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 2.04 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 1.52 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-097861
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 2.41 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.11 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap SharesIssued Shares, Issued shares 8.70M 2022-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares USD 1.33M 2023-06-30 2023 Q2 10-Q 2023-08-14 0001410578-23-001937
us-gaap StandardProductWarrantyAccrual Standard Product Warranty Accrual USD 2.16M 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-097861
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -1.53M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap StockIssued1 Stock Issued USD 376,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067381
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 1.15M 2023-04-17 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 32,758 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 109,670 2025-09-03 2025 Q3 10-Q 2025-11-10 0001213900-25-107902
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 2.50M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationForfeited Shares Issued, Shares, Share-based Payment Arrangement, Forfeited shares 5.51M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 2.00M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 10.98M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 27.49M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan Stock Issued During Period, Value, Employee Stock Ownership Plan USD 104,000 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-10 0001213900-26-086974
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 104,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 97,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 27.78M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 204,000 2025-04-01 2025-06-30 2026 Q2 10-Q 2026-08-10 0001213900-26-086974
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 1.38M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001013762-25-004299
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 307,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationForfeited Shares Issued, Value, Share-based Payment Arrangement, Forfeited USD 1.57M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 109,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap StockOptionExercisePriceIncrease Stock Option, Exercise Price, Increase USD/shares 2.4 2023-10-15 2024 Q1 10-Q 2024-05-15 0001213900-24-043566
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 9.40M 2023-11-14 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 5.00M 2023-01-01 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 102,061 2023-06-30 2023 Q2 10-Q 2023-08-14 0001410578-23-001937
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 429,299 2023-04-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001410578-23-001937
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 37.26M 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-03 0001104659-23-040842
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 391,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2023-03-31 2023 Q1 10-Q 2023-05-15 0001104659-23-060855
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 10.24 2023-03-31 2023 Q1 10-Q 2023-05-15 0001104659-23-060855
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 400.00M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001104659-23-060855
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 42.50M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001104659-22-118526
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 4.31M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001104659-23-060855
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD -4.11M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-097861
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted USD -4.11M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-097861
us-gaap UndistributedEarningsLossAvailableToCommonShareholdersBasic Undistributed Earnings (Loss) Available to Common Shareholders, Basic USD -159,000 2023-07-01 2023-09-30 2023 Q3 10-Q/A 2024-01-17 0001213900-24-004149
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD -9.38M 2023-01-01 2023-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043566
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -512,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-17 0001104659-21-068312
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 452,000 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions USD 1.03M 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2023-06-30 2023 Q2 10-Q 2023-08-14 0001410578-23-001937
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 964,000 2024-01-01 2024-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 63,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap UnrecoveredProductionCostsExcessOfEstimatedAverageUnitCost Unrecovered Production Costs, Excess of Estimated Average Unit Cost USD 6,000 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043566
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -2.62M 2025-01-01 2025-12-31 POS AM 2026-06-12 0001213900-26-068309
us-gaap WarrantExercisePriceDecrease Warrant, Exercise Price, Decrease USD/shares 1.5 2025-06-30 2025 Q2 10-Q 2025-07-31 0001213900-25-069663
us-gaap WarrantExercisePriceIncrease Warrant, Exercise Price, Increase USD/shares 1.35 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 24,000 2025-12-31 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 9.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap WeightedAverageNumberOfSharesContingentlyIssuable Weighted Average Number of Shares, Contingently Issuable shares 1.00M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028894
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 9.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001213900-26-116117
us-gaap WithdrawalFromContractHoldersFunds Withdrawal from Contract Holders Funds USD 5.00M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001213900-25-038468

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →